Ning Lang1, Huishu Yuan2, Hon J Yu3, Min-Ying Su4. 1. Department of Radiology, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing 100191, China. 2. Department of Radiology, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing 100191, China. Electronic address: huishuy@bjmu.edu.cn. 3. Tu & Yuen Center for Functional Onco-Imaging, Department of Radiological Sciences, University of California, Irvine Hall 164, Irvine, CA 92697-5020. 4. Tu & Yuen Center for Functional Onco-Imaging, Department of Radiological Sciences, University of California, Irvine Hall 164, Irvine, CA 92697-5020. Electronic address: msu@uci.edu.
Abstract
RATIONALE AND OBJECTIVES: This study aimed to evaluate the diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in differentiation of four spinal lesions by using heuristic and pharmacokinetic parameters analyzed from DCE signal intensity time course. MATERIALS AND METHODS: DCE-MRI of 62 subjects with confirmed myeloma (n = 9), metastatic cancer (n = 22), lymphoma (n = 7), and inflammatory tuberculosis (TB) (n = 24) in the spine were analyzed retrospectively. The region of interest was placed on strongly enhanced tissues. The DCE time course was categorized as the "wash-out," "plateau," or "persistent enhancement" pattern. The maximum enhancement, steepest wash-in enhancement, and wash-out slope using the signal intensity at 67 seconds after contrast injection as reference were measured. The Tofts 2-compartmental pharmacokinetic model was applied to obtain Ktrans and kep. Pearson correlation between heuristic and pharmacokinetic parameters was evaluated, and receiver operating characteristic curve analysis was performed for pairwise group differentiation. RESULTS: The mean wash-out slope was -22% ± 10% for myeloma, 1% ± 0.4% for metastatic cancer, 3% ± 3% for lymphoma, and 7% ± 10% for TB, and it could significantly distinguish myeloma from metastasis (area under the curve [AUC] = 0.884), lymphoma (AUC = 1.0), and TB (AUC = 1.0) with P = .001, and distinguish metastasis from TB (AUC = 0.741) with P = .005. The kep and wash-out slope were highly correlated (r = 0.92), and they showed a similar diagnostic performance. The Ktrans was significantly correlated with the maximum enhancement (r = 0.71) and the steepest wash-in enhancement (r = 0.85), but they had inferior diagnostic performance compared to the wash-out slope. CONCLUSIONS: DCE-MRI may provide additional diagnostic information, and a simple wash-out slope had the best diagnostic performance. The heuristic and pharmacokinetic parameters were highly correlated.
RATIONALE AND OBJECTIVES: This study aimed to evaluate the diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in differentiation of four spinal lesions by using heuristic and pharmacokinetic parameters analyzed from DCE signal intensity time course. MATERIALS AND METHODS:DCE-MRI of 62 subjects with confirmed myeloma (n = 9), metastatic cancer (n = 22), lymphoma (n = 7), and inflammatory tuberculosis (TB) (n = 24) in the spine were analyzed retrospectively. The region of interest was placed on strongly enhanced tissues. The DCE time course was categorized as the "wash-out," "plateau," or "persistent enhancement" pattern. The maximum enhancement, steepest wash-in enhancement, and wash-out slope using the signal intensity at 67 seconds after contrast injection as reference were measured. The Tofts 2-compartmental pharmacokinetic model was applied to obtain Ktrans and kep. Pearson correlation between heuristic and pharmacokinetic parameters was evaluated, and receiver operating characteristic curve analysis was performed for pairwise group differentiation. RESULTS: The mean wash-out slope was -22% ± 10% for myeloma, 1% ± 0.4% for metastatic cancer, 3% ± 3% for lymphoma, and 7% ± 10% for TB, and it could significantly distinguish myeloma from metastasis (area under the curve [AUC] = 0.884), lymphoma (AUC = 1.0), and TB (AUC = 1.0) with P = .001, and distinguish metastasis from TB (AUC = 0.741) with P = .005. The kep and wash-out slope were highly correlated (r = 0.92), and they showed a similar diagnostic performance. The Ktrans was significantly correlated with the maximum enhancement (r = 0.71) and the steepest wash-in enhancement (r = 0.85), but they had inferior diagnostic performance compared to the wash-out slope. CONCLUSIONS:DCE-MRI may provide additional diagnostic information, and a simple wash-out slope had the best diagnostic performance. The heuristic and pharmacokinetic parameters were highly correlated.
Authors: Jens Hillengass; Klaus Wasser; Stefan Delorme; Fabian Kiessling; Christian Zechmann; Axel Benner; Hans-Ulrich Kauczor; Anthony D Ho; Hartmut Goldschmidt; Thomas M Moehler Journal: Clin Cancer Res Date: 2007-01-15 Impact factor: 12.531
Authors: Teresa Kimlinger; Michael Kline; Shaji Kumar; John Lust; Thomas Witzig; S Vincent Rajkumar Journal: Haematologica Date: 2006-07-25 Impact factor: 9.941
Authors: R Erlemann; M F Reiser; P E Peters; P Vasallo; B Nommensen; C R Kusnierz-Glaz; J Ritter; A Roessner Journal: Radiology Date: 1989-06 Impact factor: 11.105
Authors: Ning Lang; Yang Zhang; Enlong Zhang; Jiahui Zhang; Daniel Chow; Peter Chang; Hon J Yu; Huishu Yuan; Min-Ying Su Journal: Magn Reson Imaging Date: 2019-02-28 Impact factor: 2.546